Korean Journal of Nephrology 2011;30(2):215-219.
Peritonitis by Achromobacter xylosoxidans in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis(CAPD): A Case Report
Ji Min Jeon, M.D.1, Yong Ki Park, M.D.1, Joon-Suk Oh, M.D.2, Sung-Min Kim, M.D.2, Yong-Hun Sin, M.D.2 and Joong-Kyung Kim, M.D.2
Division of Nephrology1
Department of Internal Medicine, Dongrae Bong Seng Hospital Division of Nephrology2
Department of Internal Medicine, Bong Seng Memorial Hospital, Busan, Korea
증례 : 지속성외래복막투석 환자에서 발생한 Achromobacter xylosoxidans에 의한 복막염 1예
전지민1, 박용기1, 오준석2, 김성민2, 신용훈2, 김중경2
동래봉생병원 신장내과1, 봉생병원 신장내과2
Peritonitis is a major cause of morbidity in continuous ambulatory peritoneal dialysis (CAPD) patients. Achromobacter xylosoxidans is a rarely reported cause of peritonitis in CAPD patients. In this report, a peritonitis case due to Achromobacter xylosoxidans in a 60-year-old male patient with end-stage renal failure receiving CAPD for 7 years, has been reported. White blood cell (WBC) count in peritoneal fluid was 3,160/mm3 with 95% neutrophil. Gram staining of the peritoneal fluid yielded gram negative rod. Empirical antibiotic therapy with ceftriaxone was initiated intraperitoneally. But drug sensitivity test revealed these regimens were resistant. On fourth hospital day, Achromobacter xylosoxidans was cultured from peritoneal effluent, the antibiotic regimen was switched to piperacillin/tazobactam intraperitoneally. The patient rapidly recovered and the WBC count of the peritoneal effluent decreased. The therapy was continued for 14 days and then the patient was discharged. The peritoneal catheter was not removed.
Key Words: Achromobacter xylosoxidans, Peritonitis, Continuous ambulatory peritoneal dialysis

Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail: registry@ksn.or.kr                

Copyright © 2024 by The Korean Society of Nephrology.

Developed in M2PI

Close layer